Skoff TH, et al. - In 2012, Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccine was recommended for women during each pregnancy to protect infants in the first months of life. Researchers performed a case-control evaluation to assess the effectiveness of this strategy on preventing pertussis in infants <2 months of age. Findings demonstrated that vaccination during pregnancy was an effective way to protect infants during the early months of life. To combat the continuing resurgence in pertussis, they recommend maximizing Tdap uptake among pregnant women.